Khiron Life Sciences Corp.

Corporate Information

A global medicinal cannabis company improving the quality of peoples' lives

TSXV: KHRN | OTCQX: KHRNF | Frankfurt: A2JMZC

Download Presentation

Khiron Life Sciences (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC) is a global health & wellness company positioned to capitalize on the fast-growing international cannabis market. With operations and sales spanning nine countries and three continents, Khiron recently became the first company fully authorized to sell medical cannabis in Colombia. As Khiron shifts toward the sales-execution phase of its business plan, it is targeting markets it perceives as having the greatest near-term revenue potential and ROIC; these countries include Colombia, Brazil, Peru, the UK, and Germany, where sales have commenced or are expected.

By 2024, Khiron aims to reach 1 million patients by leveraging its first-mover advantage, regulatory expertise, robust education platform and advanced supply chain. With a focus on creating brand loyalty, the company aims to deliver a seamless customer experience through traditional and digital channels.

Our Patients And Consumers
Come First

VERTICALLY INTEGRATED

Our Clinics

In the domestic market of Colombia and elsewhere in Latin America, Khiron Life Sciences has built partnerships with some of the region’s most respected medical associations. In coordination with these associations, a growing regional network of physicians is being created to serve as the primary distribution channel.

Our wellbeing products

At the core of Khiron’s wellbeing unit, Kuida cosmeceuticals, the first mass-market branded CBD skincare line in Latin America, is distributed at retail and online across Colombia, UK, Spain and in permissive States in the United States. Khiron’s wellbeing believes in the power of cannabis and hemp seeds as disrupters for the development of high quality mass consumption products.

Learn More

Khiron’s Global Network

We’re proud to be partnering with international brands that share our passion. Learn more about how our CPG brands around the world make a difference.

  1. Kuida: Cosmeceutical business line, sold in +300 point of sales of Colombia
  2. Magistral Preparations: Medical business line, prescribed in Khiron’s ILANS and Zerenia clinics
  3. Acceso: Supplements business line

  1. Kuida: sold in Los Angeles, CA at CannabisNow

  1. Kuida: Cosmeceutical product line, fulfilled E.U. cosmetic product regulatory requirements for 7 SKU´s

LEARN MORE ABOUT KHIRON’S FACILITY

THROUGH OUR VERTICALLY INTEGRATED PROCESS, WE INVEST IN QUALITY AT EVERY STEP OF THE WAY.

Our Facilities

  • Khiron currently owns and operates state of the art medical cannabis cultivation and processing facilities in Latin America.
  • Facilities include a 14,000 sq ft GMP compliant extraction lab and ISO 17025 compliant testing lab in Colombia. In addition, a 105,486 sq ft GAP and GMP cultivation and processing facility is currently under construction In Uruguay.

State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab include full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testing.

Physical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC & HPLC cannabinoid samples, 15 daily gas chromatography samples, and 2,000 monthly heavy metals samples. Microbiological testing lab has a capacity of up to 20 daily samples.

State-of-the-art testing lab allows the Company to fully test every aspect of its vertical integration from soil and water, to flower to extract, ensuring a high-quality product that will be delivered to patients across Latin America.

Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia

  • Solar park can generate up to 40% of the energy needs at its 5 hectare facility in Doima, Colombia
  • Project demonstrates Khiron's commitment to sustainability by reducing its carbon footprint by approximately 570 tons of CO2 a year, while decreasing operational energy costs

Cultivation capabilities operate within the most up-to-date country THC quotas assigned by the International Narcotics Control Board (INCB) to meet domestic demand, including treatment of more than 119,000 patients at the Company's ILANS clinics.

Leadership

Leadership

Khiron Life Sciences has a highly experienced management team and influential board representation including the 55th president of Mexico and former CEO of Coca Cola Mexico, Vicente Fox and Deborah Rosati who is the Founder & CEO of Women Get On Board, a leading member-based company that connects, promotes and empowers women to corporate boards.


View Management Team

View Board of Directors

Contact Us

Have business-related questions about KHRN? Or just general inquiries? Send us a message and we ́ll be happy to help.

Register Now

Be the first to try our products when they become available. Read our Privacy Policy.

Sign up for Email Alerts